Synthesis and evaluation of Ketorolac ester prodrugs for transdermal delivery
โ Scribed by Hea-Jeong Doh; Won-Jea Cho; Chul-Soon Yong; Han-Gon Choi; Jung Sun Kim; Chi-Ho Lee; Dae-Duk Kim
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 145 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
โฆ Synopsis
Alkyl esters of ketorolac were synthesized as potential prodrugs for transdermal delivery and evaluated to determine the relationship between their skin permeation characteristics and their physicochemical properties. Solubility of the prodrugs in various vehicles was determined at room temperature while lipophilicity was obtained as 1-octanol/water partition coefficients (logP) and capacity factors (k') using HPLC. Metabolism of the prodrugs to ketorolac was studied both in rat skin homogenate and in plasma. Rat skin permeation characteristics of the prodrugs saturated in propylene glycol were investigated using the Keshary-Chien permeation system at 37 degrees C. An increase in logP and capacity factor values of the prodrugs were observed in proportion to their alkyl chain length. Good linear relationship between the logP values and capacity factor was observed (r(2) = 0.92). Prodrugs were rapidly degraded to ketorolac both in the skin homogenate and in plasma following a first-order kinetics. To determine accurate amounts of prodrug permeated, both the prodrug and parent drug concentration in the receptor solution were determined in mole units. The skin permeation rate of the alkyl ester prodrugs was significantly higher with a shorter lag time than that of ketorolac. The permeation rate of ketorolac reached maximum in its 1-propyl ester form as 46.61 nmol/cm(2)/h, and a parabolic relationship was observed between the permeation rate and the logP values of the prodrugs. Alkyl ester prodrugs of ketorolac having optimum lipophilicity could improve the transdermal delivery of ketorolac.
๐ SIMILAR VOLUMES
Synthesis of novel amides and esters prodrugs of olmesartan is described. Their in vitro stability in rat plasma was tested. The results showed that the ester derivative IIa with n-octyl substituted dioxolone moiety was rapidly converted into olmesartan within 30 min. The pharmacokinetic parameters